Regeneron Pharmaceuticals, Inc.
NASDAQ:REGN 3:40:15 PM EDT
Search For a Symbol
|Market Cap (Intraday)||81.26B|
|2yr Forward PE||16.94|
Estimates Current Quarter
Regeneron Pharmaceuticals, Inc. Stock, NASDAQ:REGN
777 Old Saw Mill River Road, Tarrytown, New York 10591-6707
United States of America
Number of Employees: 11851
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically-humanized mice to produce optimized fully-human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.